1. Combination of hyperlipidemia and 17β-Estradiol induces TMJOA-like pathological changes in rats.
- Author
-
Zhao Y and Gan YH
- Subjects
- Rats, Female, Animals, Celecoxib pharmacology, Celecoxib metabolism, Cyclooxygenase 2 metabolism, Chondrocytes metabolism, Estradiol pharmacology, Estradiol metabolism, NF-kappa B metabolism, Hyperlipidemias metabolism
- Abstract
Objective: We explored whether hyperlipidemia or combination of hyperlipidemia and E2 could induce TMJOA., Materials and Methods: Four groups of female rats were treated with normal diet, normal diet with E2, high-fat diet, and high-fat diet with E2 (HFD/E2), respectively, to induce TMJOA till 8 weeks. Another three groups were then used for COX2 inhibitor celecoxib to block the induction of TMJOA. Primary condylar chondrocytes were treated with combination of E2, ox-LDL, and corresponding inhibitors for evaluating expressions of related molecules., Results: Condylar cartilage proliferation with plenty of chondrocyte apoptosis and increased staining for LOX1, nuclear NF-κB, IL-1β, and COX2 at 4 weeks and decreased condylar cartilage and increased subchondral bone density at 8 weeks were observed only in the HFD/E2 group. Celecoxib significantly alleviated the cartilage proliferation and apoptosis in the HFD/E2 group. Serum ox-LDL increased in both high-fat diet groups, while serum IL-1β increased only in the HFD/E2 group. Combination of E2 and ox-LDL synergistically induced expressions of LOX1, phosphorylated NF-κB, IL-1β, and COX2, while LOX1 inhibitor blocked the induction of phosphorylated NF-κB, and NF-κB inhibitor the induction of IL-1β, and IL-1β inhibitor the induction of COX2., Conclusion: Combination of hyperlipidemia and E2-induced TMJOA-like pathological changes through LOX1/NF-κB/IL-1β/COX2-signaling pathway., (© 2022 Wiley Periodicals LLC.)
- Published
- 2023
- Full Text
- View/download PDF